Condensed Consolidated and Combined Statements of Changes in Equity (Unaudited) - USD ($) $ in Millions	Total	Common stock	Additional paid-in capital	Retained earnings	Net parent investment	Accumulated other comprehensive income (loss) – net	Equity attributable to noncontrolling interests
Equity, beginning balance (in shares) at Dec. 31, 2021		0
Equity, beginning balance at Dec. 31, 2021	$ 16,676	$ 0	$ 0	$ 0	$ 17,692	$ (1,037)	$ 21
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income attributable to GE HealthCare	389				389
Currency translation adjustments – net of taxes	(153)					(153)
Benefit plans – net of taxes	(5)					(5)
Cash flow hedges – net of taxes	24					24
Transfers (to) from GE	(353)				(353)
Changes in equity attributable to noncontrolling interests	0
Equity, ending balance (in shares) at Mar. 31, 2022		0
Equity, ending balance at Mar. 31, 2022	$ 16,578	$ 0	0	0	17,728	(1,171)	21
Equity, beginning balance (in shares) at Dec. 31, 2022	100	0
Equity, beginning balance at Dec. 31, 2022	$ 9,362	$ 0	0	0	11,235	(1,878)	5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net transfers from Parent, including Spin-Off-related adjustments	(2,834)				(4,833)	2,000	(1)
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment (in shares)		454,000,000
Issuance of common stock in connection with the Spin-Off and reclassification of net parent investment	0	$ 5	6,397		(6,402)
Issuance of common stock in connection with employee stock plans (in shares)		1,000,000
Issuance of common stock in connection with employee stock plans	4		4
Net income attributable to GE HealthCare	372			372
Currency translation adjustments – net of taxes	57					57
Benefit plans – net of taxes	(65)					(65)
Cash flow hedges – net of taxes	(39)					(39)
Changes in equity attributable to noncontrolling interests	2						2
Share-based compensation expense	24		24
Changes in equity due to redemption value adjustments on redeemable noncontrolling interests	$ (187)			(187)
Equity, ending balance (in shares) at Mar. 31, 2023	454,617,131	455,000,000
Equity, ending balance at Mar. 31, 2023	$ 6,696	$ 5	$ 6,425	$ 185	$ 0	$ 75	$ 6